U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):
[X] Form 10-K or Form 10-KSB [ ] Form 20-F [ ] Form 11-K
[ ] Form 10-Q or Form 10-QSB [ ] Form N-SAR
For Period Ended: June 30, 1996
[ ] Transition Report on Form 10-K or Form-KSB
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q or Form 10-QSB
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: ___________________
Read attached Instruction sheet before preparing form. Please print or type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
- -------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
.......................................................
PART 1 - Registrant Information
Full name of Registrant: SOURCE SCIENTIFIC, INC.
Former Name if applicable: ALTON GROUP, INC.
Address of Principal Executive Office (Street and Number)
7390 Lincoln Way
City, State, and Zip Code
Garden Grove, California 92641
Part II - Rules 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
[ ] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[X] (b) The subject annual report, semi-annual report, transition report on
Form 10-K or Form 10-KSB, Form 20-F, 11-K or Form N-SAR, or portio
thereof will be filed on or before the fifteenth calendar day foll-
owing the described due date; or the subject quarterly report or
transition report on Form 10-Q or Form 10-QSB, or portion thereof
will be filed on or before the fifth calendar day following the
prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
<PAGE>
Part III - Narrative
State below in reasonable detail the reasons why Form 10-K and Form 10-KSB,
20-F, 11-K, 10-Q and Form 10-QSB, N-SAR, or the transition report or portion
thereof could not be filed within the prescribed period.
The Company's audited financial statements for the fiscal year ended
June 30, 1996, were not completed in sufficient time to enable the compilation
of the Company's report on Form 10-KSB. The Company believes that it will be
current in its financial reporting on or before October 11, 1996.
Part IV - Other Information
(1) Name and Telephone number of person to contact in regard to this
notification:
Catherine Curtis (714) 898-9001 extension 204
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under
Section 13 or 15(d) of the Securities Exchange
Act of 1934 or Section 30 of the Investment [X] Yes [ ] No
Company Act of 1940 during the preceding
12 months or for such shorter period
that the registrant was required to file such
report(s) been filed? If the answer is no,
identify report(s).
(3) Is it anticipated that any significant change
in results of operations from the corresponding
period for the last fiscal year will be [ ] Yes [X] No
reflected by the earnings statements to be
included in the subject report or portion
thereof?
If so: attach an explanation of the
anticipated change, both narratively and
quantitatively, and, if appropriate state the
reasons why a reasonable estimate of the
results cannot be made.
SOURCE SCIENTIFIC, INC.
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: September 26, 1996 By: /s/ CATHERINE CURTIS
------------------- --------------------
Catherine Curtis
Secretary
INSTRUCTION: The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name and title of
the person signing the form shall be typed or printed beneath the signature. If
the statement is signed on behalf of the registrant by an authorized
representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall be filed
with the form.
